NCT05890612View on ClinicalTrials.gov

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

July 13, 2029

Study Completion Date

July 13, 2029

Conditions
COVID-19
Trial Locations (1)

04631

RECRUITING

Pfizer Korea, Seoul

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05890612 - A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19 | Biotech Hunter | Biotech Hunter